loadpatents
Patent applications and USPTO patent grants for Ogawa; Gavin.The latest application filed is for "hepatitis c virus inhibitors".
Patent | Date |
---|---|
Hepatitis C virus inhibitors Grant 9,669,027 - Long , et al. June 6, 2 | 2017-06-06 |
Inhibitors of hepatitic C virus Grant 9,260,414 - McKinnell , et al. February 16, 2 | 2016-02-16 |
Hepatitis C Virus Inhibitors App 20160038483 - Long; Daniel D. ;   et al. | 2016-02-11 |
Hepatitis C virus inhibitors Grant 9,212,168 - Long , et al. December 15, 2 | 2015-12-15 |
Piperazine-piperidine compounds as hepatitis C virus inhibitors Grant 9,206,159 - Long , et al. December 8, 2 | 2015-12-08 |
Novel Inhibitors Of Hepatitic C Virus App 20150071878 - McKinnell; Robert Murray ;   et al. | 2015-03-12 |
Inhibitors of hepatitis C virus Grant 8,921,372 - McKinnell , et al. December 30, 2 | 2014-12-30 |
Piperazine-piperidine Compounds As Hepatitis C Virus Inhibitors App 20130287730 - Long; Daniel D. ;   et al. | 2013-10-31 |
Hepatitis C Virus Inhibitors App 20130115194 - LONG; Daniel D. ;   et al. | 2013-05-09 |
Novel Inhibitors Of Hepatitis C Virus App 20120114600 - McKINNELL; Robert Murray ;   et al. | 2012-05-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.